A Study to Evaluate the Effect of Vitamin D Supplementation on Insulin Sensitivity and Secretion
Primary Purpose
Diabetes Mellitus, Non-Insulin-Dependent
Status
Completed
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
Vitamin D
Sponsored by
About this trial
This is an interventional prevention trial for Diabetes Mellitus, Non-Insulin-Dependent focused on measuring Diabetes, Vitamin D, Insulin sensitivity, Insulin secretion
Eligibility Criteria
Inclusion Criteria: Male ≥30 years of age Waist circumference ≥80 cm Exclusion Criteria: Diabetic- Fasting Blood Sugar >126 mg/dl or on anti-diabetic medication BP>140/90 or on anti-hypertensive medication Receiving Vitamin D or calcium supplementation Chronic disease-renal/hepatic/malignancy/gastrointestinal On any medication within the last one month which could potentially influence insulin secretion, insulin sensitivity, Vitamin D or Calcium metabolism Febrile illness or infective morbidity in the past 10 days
Sites / Locations
- Sitaram Bhartia Institute of Science and Research
Outcomes
Primary Outcome Measures
OGIS Index, Total Insulin Secretion
Secondary Outcome Measures
HOMA
QUICKI
ISI composite
ISI stumvoll
ISI Gutt
Insulinogenic Index
Lipid profile
CRP
ApoA1
ApoB
Full Information
NCT ID
NCT00320853
First Posted
May 1, 2006
Last Updated
May 1, 2006
Sponsor
Sitaram Bhartia Institute of Science and Research
1. Study Identification
Unique Protocol Identification Number
NCT00320853
Brief Title
A Study to Evaluate the Effect of Vitamin D Supplementation on Insulin Sensitivity and Secretion
Official Title
A Pilot Study to Evaluate the Effect of Vitamin D Supplementation on Insulin Secretion and Peripheral Insulin Sensitivity
Study Type
Interventional
2. Study Status
Record Verification Date
May 2006
Overall Recruitment Status
Completed
Study Start Date
April 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
May 2006 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Sitaram Bhartia Institute of Science and Research
4. Oversight
5. Study Description
Brief Summary
The purpose of the study is to evaluate the change in insulin sensitivity and secretion indices (early markers for development of diabetes) after 4 weeks of a megadose of Vitamin D. This will also help to calculate sample size for and choose an appropriate index for a larger randomized control trial which may be required subsequently.
Detailed Description
Accumulating evidence suggests that serum Vitamin D levels may be inversely related to the prevalence of diabetes, to the concentration of glucose , insulin resistance and metabolic syndrome.The available trials have been conducted using small sample sizes in different subgroups (hemodialyzed patients , healthy volunteers , gestational diabetes and post menopausal women ) document variable results with a positive result in some (hemodialysis and gestational diabetes) and no effect in other settings(healthy volunteers and postmenopausal women).We therefore, planned this trial to study the effect of vitamin D supplementation (240,000 IU) on insulin secretion and peripheral insulin sensitivity.This will also help to calculate sample size for and choose an appropriate index for a larger randomized control trial which may be required subsequently.
Study design and comparison:Single group, open label intervention trial involving assessment of insulin sensitivity and secretion in 30 volunteers before and after 4weeks of a megadose of Vitamin D. The pre and post intervention results will be compared using the paired t test.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Non-Insulin-Dependent
Keywords
Diabetes, Vitamin D, Insulin sensitivity, Insulin secretion
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
30 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Vitamin D
Primary Outcome Measure Information:
Title
OGIS Index, Total Insulin Secretion
Secondary Outcome Measure Information:
Title
HOMA
Title
QUICKI
Title
ISI composite
Title
ISI stumvoll
Title
ISI Gutt
Title
Insulinogenic Index
Title
Lipid profile
Title
CRP
Title
ApoA1
Title
ApoB
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Male
≥30 years of age
Waist circumference ≥80 cm
Exclusion Criteria:
Diabetic- Fasting Blood Sugar >126 mg/dl or on anti-diabetic medication
BP>140/90 or on anti-hypertensive medication
Receiving Vitamin D or calcium supplementation
Chronic disease-renal/hepatic/malignancy/gastrointestinal
On any medication within the last one month which could potentially influence insulin secretion, insulin sensitivity, Vitamin D or Calcium metabolism
Febrile illness or infective morbidity in the past 10 days
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jitendra N Pande, MD
Organizational Affiliation
Sitaram Bhartia Institute of Science and Research
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jitender Nagpal, MD
Organizational Affiliation
Sitaram Bhartia Institute of Science and Research
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Abhishek Bhartia, ME
Organizational Affiliation
Sitaram Bhartia Institute of Science and Research
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Anupama Singh, MD
Organizational Affiliation
Sitaram Bhartia Institute of Science and Research
Official's Role
Study Chair
Facility Information:
Facility Name
Sitaram Bhartia Institute of Science and Research
City
New Delhi
State/Province
Delhi
ZIP/Postal Code
110016
Country
India
12. IPD Sharing Statement
Learn more about this trial
A Study to Evaluate the Effect of Vitamin D Supplementation on Insulin Sensitivity and Secretion
We'll reach out to this number within 24 hrs